Research advances in nanomedicine, immunotherapy, and combination therapy for leukemia
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Research advances in nanomedicine, immunotherapy, and combination therapy for leukemia
Authors
Keywords
-
Journal
JOURNAL OF LEUKOCYTE BIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-08-17
DOI
10.1002/jlb.5mr0620-063rr
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Size-Tunable Strategies for a Tumor Targeted Drug Delivery System
- (2020) Wenqi Yu et al. ACS Central Science
- Immune Checkpoint Inhibitors in Acute Myeloid Leukemia: Novel Combinations and Therapeutic Targets
- (2019) Maximilian Stahl et al. Current Oncology Reports
- Dual Functional Immunostimulatory Polymeric Prodrug Carrier with Pendent Indoximod for Enhanced Cancer Immunochemotherapy
- (2019) Zhuoya Wan et al. Acta Biomaterialia
- Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML)
- (2019) Susanne Hofmann et al. Journal of Clinical Medicine
- Chimeric antigen receptor T-cell therapy for acute myeloid leukemia: how close to reality?
- (2019) Katherine D. Cummins et al. HAEMATOLOGICA
- Recent Treatment Advances and the Role of Nanotechnology, Combination Products, and Immunotherapy in Changing the Therapeutic Landscape of Acute Myeloid Leukemia
- (2019) Kent T. J. Chen et al. PHARMACEUTICAL RESEARCH
- Sequentially responsive biomimetic nanoparticles with optimal size in combination with checkpoint blockade for cascade synergetic treatment of breast cancer and lung metastasis
- (2019) Wenqi Yu et al. BIOMATERIALS
- Acute myeloid leukaemia and the immune system: implications for immunotherapy
- (2019) A. John Barrett BRITISH JOURNAL OF HAEMATOLOGY
- CAR T‐Cell Therapy in Hematologic Malignancies: A Voyage in Progress
- (2019) Sarah A. Holstein et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- CAR-T “the living drugs”, immune checkpoint inhibitors, and precision medicine: a new era of cancer therapy
- (2019) Delong Liu Journal of Hematology & Oncology
- HDL-AuNPs-BMS Nanoparticle Conjugates as Molecularly Targeted Therapy for Leukemia
- (2018) Na Shen et al. ACS Applied Materials & Interfaces
- High Durable CR Rates and Preliminary Safety Profile for JCAR017 in R/R Aggressive B-NHL (TRANSCEND NHL 001 Study): A Defined Composition CD19-Directed CAR T Cell Product with Potential for Outpatient Administration
- (2018) Jeremy S. Abramson et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Targeting epigenetic pathway with gold nanoparticles for acute myeloid leukemia therapy
- (2018) Rong Deng et al. BIOMATERIALS
- Lanthanide-doped nanoparticles conjugated with an anti-CD33 antibody and a p53-activating peptide for acute myeloid leukemia therapy
- (2018) Fan Niu et al. BIOMATERIALS
- Dual PD1/LAG3 immune checkpoint blockade limits tumor development in a murine model of chronic lymphocytic leukemia
- (2018) Marina Wierz et al. BLOOD
- CAR T-cell Therapy: A New Era in Cancer Immunotherapy
- (2018) Miliotou N. Androulla et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Advances in immunotherapy for acute myeloid leukemia
- (2018) Amanda Przespolewski et al. Future Oncology
- CAR-T in the clinic: drive with care
- (2018) Rafael J. Yáñez-Muñoz et al. GENE THERAPY
- NKG2D-based chimeric antigen receptor therapy induced remission in a relapsed/refractory acute myeloid leukemia patient.
- (2018) David A. Sallman et al. HAEMATOLOGICA
- CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia
- (2018) Jeffrey E. Lancet et al. JOURNAL OF CLINICAL ONCOLOGY
- CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia
- (2018) Jinghua Wang et al. Journal of Hematology & Oncology
- Self-assembling nanoparticles based on cytarabine prodrug for enhanced leukemia treatment
- (2018) Ruiling Liu et al. JOURNAL OF MOLECULAR LIQUIDS
- The market for chimeric antigen receptor T cell therapies
- (2018) Amy Yip et al. NATURE REVIEWS DRUG DISCOVERY
- NKG2D-based chimeric antigen receptor therapy induced remission in a relapsed/refractory acute myeloid leukemia patient.
- (2018) David A. Sallman et al. HAEMATOLOGICA
- The promise of CAR T-cell therapy in aggressive B-cell lymphoma
- (2018) Ranjit Nair et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Will CAR T cell therapy have a role in AML? Promises and pitfalls
- (2018) Katherine D. Cummins et al. SEMINARS IN HEMATOLOGY
- Immunotherapy in acute myeloid leukemia and myelodysplastic syndromes: The dawn of a new era?
- (2018) Yuxin Liu et al. BLOOD REVIEWS
- CD7 CAR T Cells for the Therapy of Acute Myeloid Leukemia
- (2018) Diogo Gomes-Silva et al. MOLECULAR THERAPY
- Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Non-randomized, Open-label, Phase 2 Study
- (2018) Naval Daver et al. Cancer Discovery
- Nanoassemblies from amphiphilic cytarabine prodrug for leukemia targeted therapy
- (2017) Jing Liu et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Recent developments in immunotherapy of acute myeloid leukemia
- (2017) Felix S. Lichtenegger et al. Journal of Hematology & Oncology
- Immunotherapy in hematologic malignancies: past, present, and future
- (2017) Annie Im et al. Journal of Hematology & Oncology
- Checkpoint inhibitors in hematological malignancies
- (2017) Chi Young Ok et al. Journal of Hematology & Oncology
- Advances in adult acute lymphoblastic leukemia therapy
- (2017) Ibrahim Aldoss et al. LEUKEMIA & LYMPHOMA
- Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
- (2017) Sattva S. Neelapu et al. Nature Reviews Clinical Oncology
- Gold Nanoparticles for BCR-ABL1 Gene Silencing: Improving Tyrosine Kinase Inhibitor Efficacy in Chronic Myeloid Leukemia
- (2017) Raquel Vinhas et al. Molecular Therapy-Nucleic Acids
- Liposomal Formulations in Clinical Use: An Updated Review
- (2017) Upendra Bulbake et al. Pharmaceutics
- Colorimetric assessment of BCR-ABL1 transcripts in clinical samples via gold nanoprobes
- (2016) Raquel Vinhas et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Development of a multi-target peptide for potentiating chemotherapy by modulating tumor microenvironment
- (2016) Xu Song et al. BIOMATERIALS
- Chronic lymphocytic leukaemia
- (2016) Lydia Scarfò et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Co-infusion of haplo-identical CD19-chimeric antigen receptor T cells and stem cells achieved full donor engraftment in refractory acute lymphoblastic leukemia
- (2016) Bo Cai et al. Journal of Hematology & Oncology
- Using Gold Nanoparticles as Delivery Vehicles for Targeted Delivery of Chemotherapy Drug Fludarabine Phosphate to Treat Hematological Cancers
- (2016) Steven Song et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- Current trends in molecular diagnostics of chronic myeloid leukemia
- (2016) Raquel Vinhas et al. LEUKEMIA & LYMPHOMA
- Ipilimumab for Patients with Relapse after Allogeneic Transplantation
- (2016) Matthew S. Davids et al. NEW ENGLAND JOURNAL OF MEDICINE
- ‘Acute myeloid leukemia: a comprehensive review and 2016 update’
- (2016) I De Kouchkovsky et al. Blood Cancer Journal
- Drug conjugated nanoparticles activated by cancer cell specific mRNA
- (2016) Nathan P. Gossai et al. Oncotarget
- PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia
- (2015) F. McClanahan et al. BLOOD
- Liposomes as nanomedical devices
- (2015) Giuseppina Bozzuto et al. International Journal of Nanomedicine
- Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor
- (2015) James N. Kochenderfer et al. JOURNAL OF CLINICAL ONCOLOGY
- Chronic myeloid leukaemia
- (2015) Jane F Apperley LANCET
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche
- (2015) H Zong et al. LEUKEMIA
- CD19-Targeted Nanodelivery of Doxorubicin Enhances Therapeutic Efficacy in B-Cell Acute Lymphoblastic Leukemia
- (2015) Vinu Krishnan et al. MOLECULAR PHARMACEUTICS
- CD33-Targeted Lipid Nanoparticles (aCD33LNs) for Therapeutic Delivery of GTI-2040 to Acute Myelogenous Leukemia
- (2015) Hong Li et al. MOLECULAR PHARMACEUTICS
- Co-delivery of Pirarubicin and Paclitaxel by Human Serum Albumin Nanoparticles to Enhance Antitumor Effect and Reduce Systemic Toxicity in Breast Cancers
- (2015) Xiaoli Yi et al. MOLECULAR PHARMACEUTICS
- Design of FLT3 Inhibitor - Gold Nanoparticle Conjugates as Potential Therapeutic Agents for the Treatment of Acute Myeloid Leukemia
- (2015) Timea Simon et al. Nanoscale Research Letters
- Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy
- (2015) E. Sotillo et al. Cancer Discovery
- Design of FLT3 Inhibitor - Gold Nanoparticle Conjugates as Potential Therapeutic Agents for the Treatment of Acute Myeloid Leukemia
- (2015) Timea Simon et al. Nanoscale Research Letters
- Acute myeloid leukemia: 2014 Update on risk-stratification and management
- (2015) Elihu H. Estey AMERICAN JOURNAL OF HEMATOLOGY
- Reason for CPXcitement in AML
- (2014) J. F. Zeidner et al. BLOOD
- Phase I clinical trial of pegylated liposomal mitoxantrone plm60-s: pharmacokinetics, toxicity and preliminary efficacy
- (2014) Jianliang Yang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Efficacy of multi-functional liposomes containing daunorubicin and emetine for treatment of acute myeloid leukaemia
- (2014) Lene Myhren et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients
- (2014) R Kihara et al. LEUKEMIA
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
- (2014) M. L. Davila et al. Science Translational Medicine
- Liposomal codelivery of a synergistic combination of bioactive lipids in the treatment of acute myeloid leukemia
- (2013) Kuan-Boone Tan et al. Nanomedicine
- The Basic Principles of Chimeric Antigen Receptor Design
- (2013) Michel Sadelain et al. Cancer Discovery
- DNA demethylation in PD-1 gene promoter induced by 5-azacytidine activates PD-1 expression on Molt-4 cells
- (2011) Min Zhang et al. CELLULAR IMMUNOLOGY
- Current findings for recurring mutations in acute myeloid leukemia
- (2011) Shinichiro Takahashi Journal of Hematology & Oncology
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- (2011) M. Kalos et al. Science Translational Medicine
- The binding of flavopiridol to blood serum albumin
- (2010) Daniel Myatt et al. CHIRALITY
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
- (2010) M Hallek et al. LANCET
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
- (2009) H. Dohner et al. BLOOD
- PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model
- (2009) L. Zhang et al. BLOOD
- Safety, Pharmacokinetics, and Efficacy of CPX-1 Liposome Injection in Patients with Advanced Solid Tumors
- (2009) G. Batist et al. CLINICAL CANCER RESEARCH
- Encapsulation of mitoxantrone into pegylated SUVs enhances its antineoplastic efficacy
- (2008) ChunLei Li et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Lipid composition and grafted PEG affect in vivo activity of liposomal mitoxantrone
- (2008) ChunLei Li et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A novel liposomal formulation of flavopiridol
- (2008) X YANG et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy
- (2008) Paul Tardi et al. LEUKEMIA RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started